​

Daré Bioscience (DARE) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

DARE Stock Forecast

Daré Bioscience (DARE) stock forecast, based on 1 Wall Street analysts, predicts a 12-month average price target of $12.00, with a high of $12.00 and a low of $12.00. This represents a 271.52% increase from the last price of $3.23.

- $3 $6 $9 $12 $15 High: $12 Avg: $12 Low: $12 Last Closed Price: $3.23

DARE Stock Rating

Daré Bioscience stock's rating consensus is Buy, based on 1 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 1 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 1 0 1 Strong Sell Sell Hold Buy Strong Buy

DARE Forecast vs Benchmarks

TypeNameUpside
StockDaré Bioscience271.52%
SectorHealthcare Stocks 25.20%
IndustryBiotech Stocks 63.35%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$12.00
Last Closing Price$3.23$3.23$3.23
Upside/Downside--271.52%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 25121--4
Dec, 24121--4
Nov, 24121--4
Oct, 24131--5
Sep, 24131--5
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 24, 2024Douglas TsaoH.C. Wainwright$12.00$3.50242.86%271.52%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Oct 24, 2024H.C. WainwrightBuyBuyhold
Aug 13, 2024H.C. WainwrightBuyBuyhold

Financial Forecast

EPS Forecast

$-15 $-10 $-5 $0 $5 $10 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.91$-0.63$4.81$-0.35-----
Avg Forecast$-9.82$-7.03$-3.80$-4.46$-0.35$-1.52$-1.34$0.41$7.63
High Forecast$-13.68$-9.80$-3.80$-5.23$-0.46$-1.90$-2.47$0.21$7.63
Low Forecast$-6.98$-5.00$-3.80$-3.81$-0.24$-1.14$-0.20$0.61$7.63
Surprise %-90.73%-91.04%-226.58%-92.15%-----

Revenue Forecast

$0 $60M $120M $180M $240M $300M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported--$10.00M$2.81M-----
Avg Forecast$645.00K$1.67M$10.00M$3.38M$1.08M$3.27M$42.10M$70.18M$272.61M
High Forecast$501.39K$1.30M$10.00M$3.20M$36.52K$3.27M$42.10M$70.18M$272.61M
Low Forecast$840.22K$2.17M$10.00M$3.55M$2.12M$3.27M$42.10M$70.18M$272.61M
Surprise %----16.83%-----

Net Income Forecast

$-100M $10M $120M $230M $340M $450M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-27.40M$-38.33M$406.80M$-30.16M-----
Avg Forecast$-71.44M$-51.16M$-27.65M$-30.16M$-2.55M$-11.06M$-9.71M$2.98M$55.47M
High Forecast$-99.55M$-71.29M$-27.65M$-38.02M$-3.33M$-13.85M$-18.01M$1.53M$55.47M
Low Forecast$-50.76M$-36.35M$-27.65M$-27.72M$-1.77M$-8.26M$-1.42M$4.44M$55.47M
Surprise %-61.65%-25.09%-1571.46%------

DARE Forecast FAQ

Is Daré Bioscience stock a buy?

Daré Bioscience stock has a consensus rating of Buy, based on 1 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 1 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Daré Bioscience is a favorable investment for most analysts.

What is Daré Bioscience's price target?

Daré Bioscience's price target, set by 1 Wall Street analysts, averages $12 over the next 12 months. The price target range spans from $12 at the low end to $12 at the high end, suggesting a potential 271.52% change from the previous close price of $3.23.

How does Daré Bioscience stock forecast compare to the average forecast of its sector, industry, and investment themes?

Daré Bioscience stock forecast shows a 271.52% upside, outperforming the average forecast for the healthcare stocks sector (25.20%) and outperforming the biotech stocks industry (63.35%).

What is the breakdown of analyst ratings for Daré Bioscience over the past three months?

  • January 2025: 25.00% Strong Buy, 50.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 25.00% Strong Buy, 50.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 25.00% Strong Buy, 50.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.

What is Daré Bioscience’s EPS forecast?

Daré Bioscience's average annual EPS forecast for its fiscal year ending in December is -0.35 for 2024, a 0% decrease from the reported $-0.35 in 2023. The prediction for 2025 is $-1.52, $-1.34 for 2026, $0.41 for 2027, and $7.63 for 2028.

What is Daré Bioscience’s revenue forecast?

Daré Bioscience's average annual revenue forecast for its fiscal year ending in December is $1.08M for 2024, a -61.54% decrease from the reported $2.81M in 2023. The forecast for 2025 is $3.27M, $42.1M for 2026, $70.18M for 2027, and $272.61M for 2028.

What is Daré Bioscience’s net income forecast?

For its fiscal year ending in December, Daré Bioscience's average annual net income forecast is $-2.546M for 2024, reflecting a -91.56% decrease from the reported $-30.161M in 2023. The projection for 2025 is $-11.058M, $-9.713M for 2026, $2.98M for 2027, and $55.47M for 2028.